Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neovascular AMD”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03748784
What this trial is testing

ADVM-022 Intravitreal Gene Therapy for Wet AMD

Who this might be right for
Wet Age-related Macular DegenerationNeovascular Age-related Macular Degeneration
Adverum Biotechnologies, Inc. 30
Not applicableStudy completedNCT02291887
What this trial is testing

Genetic Analysis of Patients Responsive to Ranibizumab But Resistant to Aflibercept

Who this might be right for
Age-Related Macular Degeneration
Associated Retinal Consultants, Michigan 13
Early research (Phase 1)Study completedNCT00473928
What this trial is testing

Safety of Intravitreal POT-4 Therapy for Patients With Neovascular Age-Related Macular Degeneration (AMD)

Who this might be right for
Age-Related Macular Degeneration
Potentia Pharmaceuticals, Inc. 27
Not applicableLooking for participantsNCT07249216
What this trial is testing

Identification of Molecular Signals in Vitreous Humor Associated With Suboptimal Response to Vascular Endothelial Growth Factor (VEGF) Inhibition in Neovascular Age-related Macular Degeneration (nAMD) Within a Clinical Trial Setting

Who this might be right for
Age Related Macular Degeneration
Singapore National Eye Centre 117
Post-approval studies (Phase 4)Study completedNCT00324116
What this trial is testing

Evaluation Of Safety And Efficacy Of 0.3 Mg/Eye Macugen In Patients With Small Age-Related Macular Degeneration Lesions

Who this might be right for
Macular Degeneration
Pfizer 81
Not applicableStudy completedNCT01245387
What this trial is testing

Observational Study Of The Long-Term Effect Of Macugen In Patients With Wet Age-Related Macular Degeneration

Who this might be right for
Macular DegenerationAge-related Macular DegenerationNeovascular Macular Degeneration
Pfizer 1,001
Large-scale testing (Phase 3)Ended earlyNCT01940887
What this trial is testing

Safety and Efficacy Study of Fovista® (E10030) Intravitreous Administration in Combination With Either Avastin® or Eylea® Compared to Avastin® or Eylea® Monotherapy

Who this might be right for
Age-Related Macular Degeneration
Ophthotech Corporation 645
Testing effectiveness (Phase 2)Ended earlyNCT00414206
What this trial is testing

Safety and Efficacy of ATG003 in Patients With Wet Age-Related Macular Degeneration (AMD)

Who this might be right for
Macular Degeneration
CoMentis 343
Large-scale testing (Phase 3)Study completedNCT00523406
What this trial is testing

Comparison of Reduced Fluence Versus Standard Photodynamic Therapy (in Combination With Intravitreal Triamcinolone Acetate)

Who this might be right for
Macular Degeneration
Medical University of Vienna 40
Large-scale testing (Phase 3)Study completedNCT05161806
What this trial is testing

Study of the Safety of Use of Intravitreal SOK583A1 Provided in a Prefilled Syringe

Who this might be right for
Neovascular Age-related Macular Degeneration (nAMD)
Sandoz 30
Very early researchLooking for participantsNCT07053358
What this trial is testing

Safety and Efficacy Evaluation of LX111 Gene Therapy in nAMD Patients

Who this might be right for
Neovascular Age-related Macular Degeneration
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 10
Post-approval studies (Phase 4)Study completedNCT04774926
What this trial is testing

Study of Innovative Multimodal Imaging Biomarkers to Predict Anatomical Outcome in Naive Patients With wAMD Treated With Brolucizumab.

Who this might be right for
Neovascular Age-related Macular Degeneration
Novartis Pharmaceuticals 122
Early research (Phase 1)Study completedNCT00569140
What this trial is testing

A Phase 1, Safety, Tolerability and Pharmacokinetic Profile of Intravitreous Injections of E10030 (Anti-PDGF Pegylated Aptamer) in Subjects With Neovascular Age-Related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
Ophthotech Corporation 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT06116890
What this trial is testing

Study to Assess the Efficacy & Safety of KHK4951 in Patients With Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration (nAMD)
Kyowa Kirin Co., Ltd. 180
Early research (Phase 1)Study completedNCT00791570
What this trial is testing

Anti-VEGFR Vaccine Therapy in Treating Patients With Neovascular Maculopathy

Who this might be right for
Neovascular MaculopathyAge Related Macular Degeneration
Osaka University 17
Testing effectiveness (Phase 2)Active Not RecruitingNCT05984927
What this trial is testing

NG101 AAV Gene Therapy in Subjects With Wet Age-Related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
Elisigen, Inc. 20
Large-scale testing (Phase 3)Study completedNCT02540954
What this trial is testing

Efficacy and Safety of Two Different Aflibercept Regimens in Subjects With Neovascular Age-related Macular Degeneration (nAMD)

Who this might be right for
Macular Degeneration
Bayer 336
Testing effectiveness (Phase 2)Study completedNCT01570790
What this trial is testing

Combretastatin A4 Phosphate in Patients With Neovascular Age-Related Macular Degeneration

Who this might be right for
Combretastatin A4 PhosphateAge-related Macular DegenerationAMD+2 more
Johns Hopkins University 8
Not applicableStudy completedNCT03509623
What this trial is testing

Blood Coagulation Parameters in Patients Receiving Intravitreal Aflibercept for Age-related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration
University Hospital of Patras 47
Not applicableStudy completedNCT03324542
What this trial is testing

Real World Outcomes of Intravitreal Anti-vascular Endothelial Growth Factors for Neovascular Age Related Macular Degeneration in Taiwan

Who this might be right for
AMD
Changhua Christian Hospital 63
Next Page